Brown Miller Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$717K Buy
14,950
+430
+3% +$18.5K 0.18% 95
2026
Q1
$534K Buy
+14,520
New +$688K 0.15% 115
2025
Q3
Sell
-13,658
Closed -$943K 200
2025
Q2
$943K Buy
13,658
+2,264
+20% +$154K 0.29% 68
2025
Q1
$791K Buy
11,394
+3,178
+39% +$262K 0.27% 71
2024
Q4
$707K Buy
8,216
+3,908
+91% +$423K 0.27% 66
2024
Q3
$513K Buy
4,308
+122
+3% +$16.3K 0.2% 79
2024
Q2
$598K Buy
4,186
+30
+0.7% +$3.98K 0.25% 70
2024
Q1
$534K Buy
+4,156
New +$495K 0.24% 77

Other funds holding NVO

Brown Miller Wealth Management's NVO Position: Q2 2026 in Review

Brown Miller Wealth Management increased its Novo Nordisk (NVO) stake by 3% in Q2 2026, buying an estimated $18.5K and bringing the position to 14,950 shares worth $717K. The position accounts for 0.18% of the portfolio, ranked #95.

Brown Miller Wealth Management first reported a position in NVO in Q1 2024 and has held it in 8 quarters since. The position peaked at $943K in Q2 2025. 387 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Brown Miller Wealth Management held 14,950 shares of Novo Nordisk worth $717K as of Q2 2026.
  • Brown Miller Wealth Management bought 430 Novo Nordisk shares in Q2 2026, an estimated $18.5K.
  • Novo Nordisk made up 0.18% of Brown Miller Wealth Management's portfolio in Q2 2026, its #95 holding.
  • Brown Miller Wealth Management first reported a position in Novo Nordisk in Q1 2024 and has held it in 8 quarters since.
  • Brown Miller Wealth Management's Novo Nordisk position peaked at $943K in Q2 2025.
  • 387 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Brown Miller Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.